Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Melanoma

Free Subscription 16.03.2026 2 Ann Surg Oncol 1 Arch Pathol Lab Med 1 Cancer Lett 1 Int J Cancer 4 J Am Acad Dermatol 1 J Invest Dermatol 1 J Surg Oncol 4 Melanoma Res 1 N Engl J Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. RASHID S, Yu C, Gulati N, Agarwal P, et al
   Prognostic Implications of Primary Site in Cutaneous Head and Neck Melanoma After the Implementation of Sentinel Node Biopsy: A SEER-Based Analysis (2011-2020).
   Ann Surg Oncol. 2026 Mar 9. doi: 10.1245/s10434-026-19374.
   PubMed         Abstract available
   
   
2. SONDAK VK, Clune JE
   Gene Expression Profile-Based Tests in Melanoma: What Factors Really Matter and How Do We Evaluate Them?
   Ann Surg Oncol. 2026 Mar 7. doi: 10.1245/s10434-026-19388.
   PubMed        
   
   

   
   Arch Pathol Lab Med

3. WOJCIK JB, Desai K, Avraam K, Vandebroek A, et al
   Measurement of LAG-3 Expression Across Multiple Staining Platforms With the 17B4 Antibody Clone.
   Arch Pathol Lab Med. 2023;147:1307-1314.
   PubMed         Abstract available
   
   

   
   Cancer Lett

4. ARBEL R, Rokach L, Razi T, Tadmor T, et al
   Validation of "SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade" in an independent cohort of 4,407 patients.
   Cancer Lett. 2026;643:218319.
   PubMed         Abstract available
   
   

   
   Int J Cancer

5. KASTELEINER P, Grozinger G, Schmehl J, Flatz L, et al
   Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanoma.
   Int J Cancer. 2026 Mar 7. doi: 10.1002/ijc.70418.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

6. STRASSWIMMER J
   Melanoma Outcome Disparities in Minority Populations and the Need for Inclusive Clinical Trials for the Benefit of All.
   J Am Acad Dermatol. 2026 Mar 10:S0190-9622(26)00379.
   PubMed        
   
   
7. KONG EL, Sullivan R, Tsao H, Chen ST, et al
   Geographic Variation in the Impact of Novel Melanoma Therapies on Mortality.
   J Am Acad Dermatol. 2026 Mar 9:S0190-9622(26)00384.
   PubMed         Abstract available
   
   
8. JOSHI TP, Kannan K, Nijhawan RI
   Utility of 31-gene expression profile testing for predicting sentinel lymph node biopsy positivity in American Joint Commission on Cancer pT1b melanomas: analysis of the Surveillance, Epidemiology, End Results-DecisionDx Database.
   J Am Acad Dermatol. 2026 Mar 4:S0190-9622(26)00350.
   PubMed        
   
   
9. MULLICK N, Nambudiri VE
   Relatlimab-nivolumab: A practical overview for dermatologists.
   J Am Acad Dermatol. 2023;89:1031-1037.
   PubMed         Abstract available
   
   

   
   J Invest Dermatol

10. ZHAN Y, Dahabieh MS, Rajakumar A, Dobocan MC, et al
    Corrigendum to 'The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma': [Journal of Investigative Dermatology, Volume 135, Issue 5, May 2015, Pages 1368-1376].
    J Invest Dermatol. 2026 Mar 13:S0022-202X(25)03516.
    PubMed        
    
    

    
    J Surg Oncol

11. GEHLE DB, Morgan PW, Fitts EM, Hauser NL, et al
    Universal Risk Stratification in Stage I-III Cutaneous Melanoma Using 31-gene Expression Profiling: A Single-Center Study.
    J Surg Oncol. 2026 Mar 8. doi: 10.1002/jso.70229.
    PubMed         Abstract available
    
    

    
    Melanoma Res

12. TARHINI AA, Khaksar MA, Chen Z, Lee SJ, et al
    Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma.
    Melanoma Res. 2026 Mar 12. doi: 10.1097/CMR.0000000000001087.
    PubMed         Abstract available
    
    
13. MONAPPA V, L B, Musunuri B, Salins N, et al
    Gastric metastasis of malignant melanoma with osteosarcomatous differentiation: a rare and unusual presentation.
    Melanoma Res. 2026 Mar 9. doi: 10.1097/CMR.0000000000001094.
    PubMed         Abstract available
    
    
14. VAN GEEL JJL, Obihara NJ, van Rens DH, Boers-Sonderen MJ, et al
    Reversal of rare paraneoplastic syndromes in melanoma: fever and cutaneous melanosis.
    Melanoma Res. 2026 Mar 9. doi: 10.1097/CMR.0000000000001091.
    PubMed         Abstract available
    
    
15. NAMIR G, Elchebly M, Papadakis AI, Spatz A, et al
    FGD1 guanine nucleotide exchange factor drives secondary resistance to BRAF inhibition in melanoma.
    Melanoma Res. 2026 Mar 9. doi: 10.1097/CMR.0000000000001095.
    PubMed         Abstract available
    
    

    
    N Engl J Med

16. CASTRO-APODACA FJ, Canizalez-Roman A
    Vulvar Melanoma with Vaginal Extension.
    N Engl J Med. 2026;394:1110.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum